Isosupra Lidose

Isotretinoin, the active ingredient in Isosupra Lidose, is a retinoid presented as a oral formulation for oral use. It is indicated for the treatment of severe recalcitrant nodular acne in patients who have not responded adequately to other systemic therapies.

GNH USA supplies Isosupra Lidose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with European Union pharmaceutical regulations and undergoes rigorous quality testing before distribution. It is packaged in tamper‑evident containers to maintain stability during transport.

Isotretinoin is a retinoid used in the management of severe acne conditions.

Severe recalcitrant nodular acne: reduces inflammatory nodules and promotes long‑term remission. Severe acne vulgaris: decreases comedones and papules when other therapies fail. Cystic acne: limits cyst formation and improves skin appearance.

Isotretinoin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dry skin: excessive epidermal dryness and scaling. - Cheilitis: cracking and inflammation of the lips. - Elevated triglycerides: increase in blood lipid levels. - Headache: mild to moderate head discomfort.

Serious or Rare Side Effects: - Severe depression or suicidal ideation: mood disturbances requiring immediate attention. - Inflammatory bowel disease: onset or worsening of Crohn’s disease or ulcerative colitis. - Liver toxicity: elevated transaminases indicating hepatic injury. - Teratogenicity: high risk of birth defects if exposure occurs during pregnancy.

When prescribing isotretinoin, clinicians should observe several safety precautions to minimize risks.

- Pregnancy contraindication: avoid use in pregnant women and ensure effective contraception. - Liver monitoring: assess hepatic enzymes before and during therapy. - Lipid monitoring: check serum triglycerides and cholesterol regularly. - Vitamin A avoidance: do not combine with other vitamin A derivatives or retinoids. - Mood assessment: monitor patients for signs of depression or suicidal thoughts. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Isotretinoin can interact with other medicines, affecting safety or efficacy.

Major Interactions (Avoid): - Tetracyclines: concurrent use may increase risk of intracranial hypertension. - Vitamin A supplements or other retinoids: additive toxicity and severe hypervitaminosis A. - Systemic steroids: may reduce isotretinoin effectiveness and increase adverse effects.

Moderate Interactions (Monitor Closely): - Oral contraceptives: isotretinoin may reduce contraceptive efficacy; additional barrier methods recommended. - Anticoagulants (e.g., warfarin): potential for altered coagulation parameters. - Phenytoin: may decrease isotretinoin plasma levels, reducing therapeutic effect.